Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
Latest Hotspot
8 min read
Gyrate atrophy of choroid and retina Indication Strategy Report 2026: OAT, Trials and Deals
3 August 2026
2026 Gyrate atrophy of choroid and retina indication strategy covering epidemiology, OAT biology, active trials, transactions, unmet need, competition and market…
Latest Hotspot
8 min read
Oguchi disease Indication Strategy Report 2026: SAG, Trials and Deals
3 August 2026
2026 Oguchi disease indication strategy covering epidemiology, SAG biology, active trials, transactions, unmet need, competition and market attractiveness.
Latest Hotspot
8 min read
Norrie disease Indication Strategy Report 2026: NDP, Trials and Deals
3 August 2026
2026 Norrie disease indication strategy covering epidemiology, NDP biology, active trials, transactions, unmet need, competition and market attractiveness.
Latest Hotspot
8 min read
Polypoidal choroidal vasculopathy Indication Strategy Report 2026: VEGF, Trials and Deals
3 August 2026
2026 Polypoidal choroidal vasculopathy indication strategy covering epidemiology, VEGF biology, active trials, transactions, unmet need, competition and market…
Latest Hotspot
8 min read
Idiopathic juxtafoveal retinal telangiectasia Indication Strategy Report 2026: VEGF, Trials and Deals
3 August 2026
2026 Idiopathic juxtafoveal retinal telangiectasia indication strategy covering epidemiology, VEGF biology, active trials, transactions, unmet need, competition…
Latest Hotspot
8 min read
Persistent fetal vasculature Indication Strategy Report 2026: VEGF, Trials and Deals
3 August 2026
2026 Persistent fetal vasculature indication strategy covering epidemiology, VEGF biology, active trials, transactions, unmet need, competition and market…
Latest Hotspot
8 min read
Frosted branch angiitis Indication Strategy Report 2026: TNF, Trials and Deals
3 August 2026
2026 Frosted branch angiitis indication strategy covering epidemiology, TNF biology, active trials, transactions, unmet need, competition and market attractiveness.
Latest Hotspot
8 min read
Acute zonal occult outer retinopathy Indication Strategy Report 2026: CD20, Trials and Deals
3 August 2026
2026 Acute zonal occult outer retinopathy indication strategy covering epidemiology, CD20 biology, active trials, transactions, unmet need, competition and…
Latest Hotspot
8 min read
Retinal vasculitis Indication Strategy Report 2026: TNF, Trials and Deals
3 August 2026
2026 Retinal vasculitis indication strategy covering epidemiology, TNF biology, active trials, transactions, unmet need, competition and market attractiveness.
Latest Hotspot
8 min read
Diffuse subretinal fibrosis syndrome Indication Strategy Report 2026: TGF-beta, Trials and Deals
3 August 2026
2026 Diffuse subretinal fibrosis syndrome indication strategy covering epidemiology, TGF-beta biology, active trials, transactions, unmet need, competition and…
Latest Hotspot
8 min read
Serpiginous choroiditis Indication Strategy Report 2026: TNF, Trials and Deals
3 August 2026
2026 Serpiginous choroiditis indication strategy covering epidemiology, TNF biology, active trials, transactions, unmet need, competition and market attractiveness.
Latest Hotspot
8 min read
Punctate inner choroidopathy Indication Strategy Report 2026: TNF, Trials and Deals
3 August 2026
2026 Punctate inner choroidopathy indication strategy covering epidemiology, TNF biology, active trials, transactions, unmet need, competition and market…